Search company, investor...



Other Investors | Alive


BRAVIS is a software and system house. It develops high-end internet-based video conference systems.

Headquarters Location

Calauer Straße 70

Cottbus, 03048,


Missing: BRAVIS's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: BRAVIS's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest BRAVIS News

Sun World Expands Footprint in Southern Hemisphere

Dec 21, 2021

Sun World International, LLC (Sun World), today announced it has added several marketers to its licensee lineup in the Southern Hemisphere. These include two newly licensed marketers in Peru, PuraFruit and Pampa Baja, as well as Bravis in Brazil and EXSA in South Africa. ... Continue reading: Sun World Expands Footprint in Southern Hemisphere.

BRAVIS Frequently Asked Questions (FAQ)

  • Where is BRAVIS's headquarters?

    BRAVIS's headquarters is located at Calauer Straße 70, Cottbus.

  • What is BRAVIS's latest funding round?

    BRAVIS's latest funding round is Other Investors.

  • Who are the investors of BRAVIS?

    Investors of BRAVIS include High-Tech Grunderfonds and Brandenburg Kapital.

  • Who are BRAVIS's competitors?

    Competitors of BRAVIS include Allergan.

Compare BRAVIS to Competitors

Pfizer Logo

Pfizer (NYSE: PFE) offers a diversified health care portfolio including human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer products. It works across various markets to promote wellness, prevention, treatments, and cures that challenge feared diseases. The company collaborates with health care providers, governments, and local communities to support and expand access to reliable, affordable health care around the world. The company was founded in 1849 and is based in New York, New York.

FoodMarble Logo

FoodMarble has developed a personal digestive tracker. Based on validated clinical technology, this tiny breath test device and app can be used with the help of AI to help people work out what foods are most compatible with their unique digestive system.

Civica Rx Logo
Civica Rx

Civica Rx is a not-for-profit generic drug company that will help patients by addressing shortages and high prices of lifesaving generic medications.

Syntr Health Technologies Logo
Syntr Health Technologies

Syntr Health Technologies specializes in the micro fragmentation of adipose tissue for body contouring. The company was founded in 2016 and is based in Irvine, California.

HAPLN Science

HAPLN Science is a drug development company that focuses on anti-aging therapies that can reverse tissue and organ degeneration. The company's products include treatments for degenerative arthritis, skin aging treatment, hair loss, and connective tissue disease. HAPLN Science was founded in 2018 and is based in Seongnam, South Korea.

Celgene Logo

Celgene is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases through next-generation solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation. On November 21, 2019, Celgene was acquired by Bristol-Myers Squibb at a valuation of $74B.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.